MedTrace Logo

Evaluate the Usability of the Neuro-trigger Artificial Eye Blinking Stimulation Device in Patients With Paralysis of the Facial Nerve.

NCT06069128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2024-09-19

No results posted yet for this study

Summary

This is a single-center, open-label clinical study. Up to 11 subjects will be enrolled to use the Neuro-trigger device for blinking stimulation for a duration of 14 days.

Conditions

  • Paralysis
  • Paralysis; Eye
  • Paralysis; Bell

Interventions

DEVICE

Neurotrigger Basic. eye blinking stimulator

NeuroTrigger Basic is intended to stimulate healthy muscles in order to improve or facilitate muscle performance for maintaining/increasing muscle range of motion and for the prevention or retardation of disuse atrophy.

Sponsors & Collaborators

  • Neurotrigger Ltd

    lead INDUSTRY

Principal Investigators

  • Daniel Keidar, Dr · Tel Aviv sourasky medical center ichilov

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-08-01
Completion
2024-09-05

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06069128 on ClinicalTrials.gov